DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Selepressin
Selepressin
Copyright by Ernesto Lopez 2015
Classification Decisions Taken by the Harmonized System Committee from the 47Th to 60Th Sessions (2011
1 Advances in Therapeutic Peptides Targeting G Protein-Coupled
Vasopressin, Norepinephrine, and Vasodilatory Shock After Cardiac Surgery Another “VASST” Difference?
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0192440 A1
Distribution and Relative Expression of Vasoactive Receptors on Arteries Xinhao Liu1,3, Dan Luo1,3, Jie Zhang2 & Lei Du1*
Terlipressin Or Norepinephrine in Septic Shock: Do We Have the Answer?
(12) Patent Application Publication (10) Pub. No.: US 2016/0354315 A1 Li (43) Pub
Stembook 2018.Pdf
1 a Global Perspective on Vasoactive Agents in Shock
Supplementary Data
WHO-EMP-RHT-TSN-2018.1-Eng.Pdf
Implication De La Vasopressine Dans L'hypoperfusion Tissulaire Au Cours Du Choc Cardiogénique Compliquant L'infarctus Du Myocarde
Discovery Consists of Seeing What Everybody Has Seen, And
(INN) for Biological and Biotechnological Substances
A Global Perspective on Vasoactive Agents in Shock Djillali Annane1*, Lamia Ouanes‑Besbes2, Daniel De Backer3, Bin DU4, Anthony C
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
International Guidelines for Management of Sepsis and Septic Shock: 2016
Top View
Adrenergic Agents
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2008
Vasopressin and Its Analogues in Shock States: a Review Julien Demiselle1, Nicolas Fage1, Peter Radermacher2 and Pierre Asfar1*
Selepressin, a Novel Selective Vasopressin V1A
Vasopressin in Vasodilatory Shock
Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
Role of Vasopressin in Current Anesthetic Practice
And Vasopressor-Free Days in Patients with Septic Shock the SEPSIS-ACT Randomized Clinical Trial
INN-Nimet 1 27.11.2018 a Abacavir Abacavirum Abakaviiri Abagovomab
Vasoplegia Treatments: the Past, the Present, and the Future
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Flourous Metabolically Stable Peptide Analogs
2019 HLI Annual Report
(INN) for Biological and Biotechnological Substances
Campaña Para Sobrevivir a La Sepsis: Recomendaciones Internacionales Para El Tratamiento De La Sepsis Y El Choque Septicémico: 2016
Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit
Hipofizer Hormonlar
Enduring Materials Application – Medical Grand Rounds #1886
W. Joost Wiersinga Christopher W. Seymour Editors
Study Protocol-17534; Ver.4.0 Clinical Trial Protocol Supersedes: 3.0 Page 1 of 96
Protective Mechanism of the Selective Vasopressin V1A Receptor Agonist
INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
(12) United States Patent (10) Patent No.: US 9,388,214 B2 Wisniewski Et Al